Research / CRS / Fundamental state Inspectable configuration
State dimensions Filing 0000017843-19-000058 General Corporate
Debt relative to revenue 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
23.13% · OPTIONAL · VALID
Capex intensity 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
7.57% · OPTIONAL · VALID
Operating cash generation 78th Own-history percentile · N=9
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
9.76% · OPTIONAL · VALID
Revenue growth 65th Own-history percentile · N=17
Evidence method Yoy · gp.fundamentals.revenue
10.31% · CORE · VALID
Inventory pressure 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
33.09% · OPTIONAL · VALID
Gross margin 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
18.69% · CORE · VALID
Operating margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
10.14% · CORE · VALID
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.98% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.74% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 50 states Self-history eligible
Sep 30, 2021 8/8 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 90.01%
Current 23.13%
Delta -66.88% Capex Intensity Decreased
Previous 8.03%
Current 7.57%
Delta -0.46% Cash Generation Increased
Previous 1.64%
Current 9.76%
Delta 8.12% Growth Increased
Previous 6.59%
Current 10.31%
Delta 3.72% Inventory Pressure Decreased
Previous 141.17%
Current 33.09%
Delta -108.08% Margin Decreased
Previous 20.20%
Current 18.69%
Delta -1.51% Profitability Decreased
Previous 12.00%
Current 10.14%
Delta -1.86% Sbc Intensity Decreased
Previous 0.75%
Current 0.74%
Delta -0.01% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.